Sort
261,768 grants matching “gene therapy”
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,355Ira A Tabas · Columbia University Health Sciences · R35 · FY2021 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,347Ira A Tabas · Columbia University Health Sciences · R35 · FY2022 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,337Ira A Tabas · Columbia University Health Sciences · R35 · FY2023 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,319Ira A Tabas · Columbia University Health Sciences · R35 · FY2025 · HL
Oncogenic mechanisms and molecular targets in lymphoma
$971,205Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Molecular diagnosis and outcome prediction in lymphoma
$971,205Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Oncogenic mechanisms and molecular targets in myeloma
$971,205Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
$971,140Michael Karin · University Of California, San Diego · U01 · FY2022 · CA
Antimicrobial and Regenerative Treatment for Oral Mucositis
$970,980Shenda Baker · Synedgen, Inc. · R44 · FY2012 · DE
Identifying Inborn Genetic Susceptibility to Development of Cancer Metastasis
$970,906Sanford D Markowitz · Case Western Reserve University · R01 · FY2012 · CA
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$970,881Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Studies of Human T Regulatory Cells
$970,827Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Novel Small-Molecule Therapies for CF
$970,729Alan S Verkman · University Of California, San Francisco · P30 · FY2019 · DK
Development and Use of Network Infrastructure for High-Throughput GWA Studies
$970,601Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2007 · HG
Very Low Frequency EPR Imaging in Vivo Phisiology P41 EB02034
$970,524Howard J Halpern · University Of Chicago · P41 · FY2009 · EB
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$970,435Katharine June Bar · University Of Pennsylvania · R01 · FY2022 · MH
Office of Cancer Genomics
$970,411Douglas R. Lowy · Office Of The Director, Nci · ZIA · FY2011 · CA
Chemical Stabilization of shRNAs and their development as hepatitis C drugs
$970,401Brian H. Johnston · Somagenics, Inc. · R44 · FY2012 · AI
Mapping Drug Resistance Genes in Plasmodium falciparum
$970,185Tim J Anderson · Texas Biomedical Research Institute · R01 · FY2023 · AI
Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.
$970,180Scott W Wong · Oregon Health & Science University · R01 · FY2019 · CA
Single-cell genomic profiling to identify immune signatures of bacterial sepsis in humans
$970,158Marcia B Goldberg · Massachusetts General Hospital · R01 · FY2025 · AI
Generation of functional organs and tissues using organism interspecific blastocyst complementation
$970,000Pradeep Reddy Dubbaka Venu · Salk Institute For Biological Studies · DP1 · FY2020 · DK
Core Grant for Vision Research
$970,000James D Zieske · Schepens Eye Research Institute · P30 · FY2011 · EY
Generation of functional organs and tissues using organism interspecific blastocyst complementation
$970,000Juan Carlos Carlos Izpisua Belmonte · Salk Institute For Biological Studies · DP1 · FY2018 · DK
Core Grant for Vision Research
$970,000Pablo Argueso · Schepens Eye Research Institute · P30 · FY2014 · EY